tiprankstipranks
RemeGen Co. Ltd. Class H (REGMF)
OTHER OTC:REGMF
US Market

RemeGen Co. Ltd. Class H (REGMF) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

REGMF Analyst Ratings

Moderate Buy
6Ratings
Moderate Buy
4 Buy
2 Hold
0 Sell
Based on 6 analysts giving stock ratings to
RemeGen
Co. Ltd. Class H
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

REGMF Stock 12 Month Forecast

Average Price Target

$15.29
▲(42.67% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for RemeGen Co. Ltd. Class H in the last 3 months. The average price target is $15.29 with a high forecast of $17.99 and a low forecast of $11.40. The average price target represents a 42.67% change from the last price of $10.72.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"$4","11":"$11","18":"$18","7.5":"$7.5","14.5":"$14.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":17.989544499999997,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$17.99</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.293875216666667,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$15.29</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.403152799999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$11.40</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,7.5,11,14.5,18],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.52,11.094580346153846,11.669160692307692,12.243741038461538,12.818321384615384,13.39290173076923,13.967482076923076,14.54206242307692,15.116642769230769,15.691223115384613,16.26580346153846,16.840383807692305,17.41496415384615,{"y":17.989544499999997,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.52,10.88722117051282,11.25444234102564,11.621663511538461,11.988884682051282,12.356105852564102,12.723327023076923,13.090548193589743,13.457769364102564,13.824990534615385,14.192211705128205,14.559432875641026,14.926654046153846,{"y":15.293875216666667,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.52,10.58793483076923,10.65586966153846,10.723804492307691,10.791739323076923,10.859674153846154,10.927608984615384,10.995543815384615,11.063478646153845,11.131413476923075,11.199348307692308,11.267283138461538,11.335217969230769,{"y":11.403152799999999,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.06,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.06,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5.06,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.9,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.275,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.45,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.949,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.949,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.05,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.605,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.52,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$17.99Average Price Target$15.29Lowest Price Target$11.40
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Nomura Analyst forecast on REGMF
Unknown Analyst
Nomura
Not Ranked
Nomura
$11.4
Hold
6.37%
Upside
Reiterated
07/24/26
Nomura Keeps Their Hold Rating on RemeGen Co. Ltd. Class H (9995)
J.P. Morgan Analyst forecast on REGMF
J.P. Morgan
J.P. Morgan
$16.45
Buy
53.42%
Upside
Reiterated
06/09/26
J.P. Morgan Sticks to Their Buy Rating for RemeGen Co. Ltd. Class H (9995)
UBS Analyst forecast on REGMF
Unknown Analyst
UBS
Not Ranked
UBS
$17.99
Buy
67.81%
Upside
Reiterated
06/08/26
RemeGen Co. Ltd. Class H (9995) Gets a Buy from UBS
Morgan Stanley Analyst forecast on REGMF
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
$12.49
Hold
16.55%
Upside
Reiterated
05/28/26
Morgan Stanley Keeps Their Hold Rating on RemeGen Co. Ltd. Class H (9995)
Shenwan Hongyuan Analyst forecast on REGMF
Unknown Analyst
Shenwan Hongyuan
Not Ranked
Shenwan Hongyuan
$15.94
Buy
48.66%
Upside
Reiterated
05/14/26
Shenwan Hongyuan Keeps Their Buy Rating on RemeGen Co. Ltd. Class H (9995)
First Shanghai Securities Analyst forecast on REGMF
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
$17.49
Buy
63.17%
Upside
Reiterated
05/12/26
RemeGen Co. Ltd. Class H (9995) Gets a Buy from First Shanghai Securities
CICC Analyst forecast on REGMF
Unknown Analyst
CICC
Not Ranked
CICC
$17.05
Buy
59.02%
Upside
Reiterated
04/02/26
CICC Reaffirms Their Buy Rating on RemeGen Co. Ltd. Class H (9995)
Bank of China Analyst forecast on REGMF
Unknown Analyst
Bank of China
Not Ranked
Bank of China
$16.19
Buy
51.04%
Upside
Reiterated
03/31/26
RemeGen Co. Ltd. Class H (9995) Gets a Buy from Bank of China
BOCOM International Holdings Company Analyst forecast on REGMF
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
$17.34
Buy
61.75%
Upside
Reiterated
03/31/26
RemeGen Co. Ltd. Class H (9995) Gets a Buy from BOCOM International Holdings Company
CLSA
$13.13$17.45
Buy
62.82%
Upside
Reiterated
03/27/26
We lift our target price from HK$103.00 to HK$136.90. Maintain Outperform.
Zhongtai Securities Analyst forecast on REGMF
Unknown Analyst
Zhongtai Securities
Not Ranked
Zhongtai Securities
$14.53
Buy
35.58%
Upside
Upgraded
01/20/26
RemeGen Co. Ltd. Class H (9995) was upgraded to a Buy Rating at Zhongtai Securities
Citic Securities Analyst forecast on REGMF
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
$12.37
Buy
15.36%
Upside
Reiterated
12/01/25
Citic Securities Remains a Buy on RemeGen Co. Ltd. Class H (9995)
CCB Intl. Analyst forecast on REGMF
Unknown Analyst
CCB Intl.
Not Ranked
CCB Intl.
$15.3
Buy
42.72%
Upside
Reiterated
11/14/25
Huatai Securities Analyst forecast on REGMF
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$17.84
Buy
66.46%
Upside
Reiterated
10/19/25
RemeGen Co. Ltd. Class H (9995) Gets a Buy from Huatai Securities
Macquarie Analyst forecast on REGMF
Macquarie
Macquarie
$6.5$8.16
Sell
-23.88%
Downside
Reiterated
09/08/25
Macquarie Reaffirms Their Sell Rating on RemeGen Co. Ltd. Class H (9995)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Nomura Analyst forecast on REGMF
Unknown Analyst
Nomura
Not Ranked
Nomura
$11.4
Hold
6.37%
Upside
Reiterated
07/24/26
Nomura Keeps Their Hold Rating on RemeGen Co. Ltd. Class H (9995)
J.P. Morgan Analyst forecast on REGMF
J.P. Morgan
J.P. Morgan
$16.45
Buy
53.42%
Upside
Reiterated
06/09/26
J.P. Morgan Sticks to Their Buy Rating for RemeGen Co. Ltd. Class H (9995)
UBS Analyst forecast on REGMF
Unknown Analyst
UBS
Not Ranked
UBS
$17.99
Buy
67.81%
Upside
Reiterated
06/08/26
RemeGen Co. Ltd. Class H (9995) Gets a Buy from UBS
Morgan Stanley Analyst forecast on REGMF
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
$12.49
Hold
16.55%
Upside
Reiterated
05/28/26
Morgan Stanley Keeps Their Hold Rating on RemeGen Co. Ltd. Class H (9995)
Shenwan Hongyuan Analyst forecast on REGMF
Unknown Analyst
Shenwan Hongyuan
Not Ranked
Shenwan Hongyuan
$15.94
Buy
48.66%
Upside
Reiterated
05/14/26
Shenwan Hongyuan Keeps Their Buy Rating on RemeGen Co. Ltd. Class H (9995)
First Shanghai Securities Analyst forecast on REGMF
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
$17.49
Buy
63.17%
Upside
Reiterated
05/12/26
RemeGen Co. Ltd. Class H (9995) Gets a Buy from First Shanghai Securities
CICC Analyst forecast on REGMF
Unknown Analyst
CICC
Not Ranked
CICC
$17.05
Buy
59.02%
Upside
Reiterated
04/02/26
CICC Reaffirms Their Buy Rating on RemeGen Co. Ltd. Class H (9995)
Bank of China Analyst forecast on REGMF
Unknown Analyst
Bank of China
Not Ranked
Bank of China
$16.19
Buy
51.04%
Upside
Reiterated
03/31/26
RemeGen Co. Ltd. Class H (9995) Gets a Buy from Bank of China
BOCOM International Holdings Company Analyst forecast on REGMF
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
$17.34
Buy
61.75%
Upside
Reiterated
03/31/26
RemeGen Co. Ltd. Class H (9995) Gets a Buy from BOCOM International Holdings Company
CLSA
$13.13$17.45
Buy
62.82%
Upside
Reiterated
03/27/26
We lift our target price from HK$103.00 to HK$136.90. Maintain Outperform.
Zhongtai Securities Analyst forecast on REGMF
Unknown Analyst
Zhongtai Securities
Not Ranked
Zhongtai Securities
$14.53
Buy
35.58%
Upside
Upgraded
01/20/26
RemeGen Co. Ltd. Class H (9995) was upgraded to a Buy Rating at Zhongtai Securities
Citic Securities Analyst forecast on REGMF
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
$12.37
Buy
15.36%
Upside
Reiterated
12/01/25
Citic Securities Remains a Buy on RemeGen Co. Ltd. Class H (9995)
CCB Intl. Analyst forecast on REGMF
Unknown Analyst
CCB Intl.
Not Ranked
CCB Intl.
$15.3
Buy
42.72%
Upside
Reiterated
11/14/25
Huatai Securities Analyst forecast on REGMF
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$17.84
Buy
66.46%
Upside
Reiterated
10/19/25
RemeGen Co. Ltd. Class H (9995) Gets a Buy from Huatai Securities
Macquarie Analyst forecast on REGMF
Macquarie
Macquarie
$6.5$8.16
Sell
-23.88%
Downside
Reiterated
09/08/25
Macquarie Reaffirms Their Sell Rating on RemeGen Co. Ltd. Class H (9995)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
ZURAZura Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering RemeGen Co. Ltd. Class H

3 Months
Yang HuangJ.P. Morgan
Success Rate
3/5 ratings generated profit
60%
Average Return
+4.42%
Copying Yang Huang's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +4.42% per trade.
1 Year
Yang HuangJ.P. Morgan
Success Rate
3/5 ratings generated profit
60%
Average Return
+22.00%
Copying Yang Huang's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +22.00% per trade.
2 Years
Success Rate
3/5 ratings generated profit
60%
Average Return
+105.20%
Copying Matthew Yan's trades and holding each position for 2 Years would result in 60.00% of your transactions generating a profit, with an average return of +105.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

REGMF Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
1
0
2
2
2
Buy
6
8
4
2
0
Hold
0
1
1
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
9
7
6
3
In the current month, REGMF has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. REGMF average Analyst price target in the past 3 months is 15.29.
Each month's total comprises the sum of three months' worth of ratings.

REGMF Financial Forecast

REGMF Earnings Forecast

The previous quarter’s earnings for REGMF were $0.09.
The previous quarter’s earnings for REGMF were $0.09.

REGMF Sales Forecast

Next quarter’s sales forecast for REGMF is $396.63M with a range of $396.63M to $396.63M. The previous quarter’s sales results were $94.43M. REGMF beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year REGMF has Outperformed its overall industry.
Next quarter’s sales forecast for REGMF is $396.63M with a range of $396.63M to $396.63M. The previous quarter’s sales results were $94.43M. REGMF beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year REGMF has Outperformed its overall industry.

REGMF Stock Forecast FAQ

What is REGMF’s average 12-month price target, according to analysts?
Based on analyst ratings, RemeGen Co. Ltd. Class H’s 12-month average price target is 15.29.
    What is REGMF’s upside potential, based on the analysts’ average price target?
    RemeGen Co. Ltd. Class H has 42.67% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is REGMF a Buy, Sell or Hold?
          RemeGen Co. Ltd. Class H has a consensus rating of Moderate Buy which is based on 4 buy ratings, 2 hold ratings and 0 sell ratings.
            What is RemeGen Co. Ltd. Class H’s price target?
            The average price target for RemeGen Co. Ltd. Class H is 15.29. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $17.99 ,the lowest forecast is $11.40. The average price target represents 42.67% Increase from the current price of $10.72.
              What do analysts say about RemeGen Co. Ltd. Class H?
              RemeGen Co. Ltd. Class H’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of REGMF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.